ENCell Co., Ltd.
Biopharmaceutical CDMO providing services for advanced cell and gene therapies.
456070 | KO
Overview
Corporate Details
- ISIN(s):
- KR7456070002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 송파대로 201 17층(송파테라타워2 A동), 서울특별시
- Website:
- http://www.encellinc.com/en/
- Sector:
- Manufacturing
Description
ENCell Co., Ltd. is a biopharmaceutical company specializing in advanced cell and gene therapies (CGT). The company's primary focus is providing Contract Development and Manufacturing Organization (CDMO) services, supported by globally recognized GMP facilities. Its offerings include process development, manufacturing, and contract quality testing (CQT) for a diverse portfolio of advanced therapies, including MSC, CAR-T, CAR-NK, and iPSC-derived cell therapies. ENCell leverages proprietary technologies such as the ROCKET Platform for multi-product GMP production and a next-generation stem cell platform designed to enhance yield and efficacy. In addition to its CDMO business, the company develops its own therapeutic pipeline. This internal research and development focuses on next-generation stem cell treatments, cancer immunotherapy, and AAV-based gene therapies, with a program for Duchenne Muscular Dystrophy in development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-15 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-08-18 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청) (샤르코마리투스(CharcotMarieTooth disease, CMT…
|
Korean | 14.8 KB | ||
| 2025-08-14 00:00 |
반기보고서 (2025.06)
|
Korean | 1.0 MB | ||
| 2025-07-03 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 9.8 KB | ||
| 2025-05-28 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 9.4 KB | ||
| 2025-05-20 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 108.4 KB | ||
| 2025-05-15 00:00 |
분기보고서 (2025.03)
|
Korean | 861.9 KB | ||
| 2025-05-08 00:00 |
주식매수선택권부여에관한신고
|
Korean | 17.8 KB | ||
| 2025-04-11 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 118.1 KB | ||
| 2025-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2025-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-11 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-03-28 00:00 |
정기주주총회결과
|
Korean | 22.7 KB | ||
| 2025-03-20 00:00 |
감사보고서제출
|
Korean | 18.7 KB |
Automate Your Workflow. Get a real-time feed of all ENCell Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ENCell Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ENCell Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
